US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

693.03

+4.110.60%

Number of Gainers:71

Number of Losers:69

Number of Flat:14

PE:- -

High:698.21

Open:689.82

Low:685.07

Close:688.92

Volume:272.16M

Turnover:8.90B

Market Cap:479.85B

Float Cap:365.12B

Loading ...

TScan Therapeutics Cuts Workforce 75% in Reorganization to Focus on in Vivo Solid Tumor Cell Therapy

TScan Therapeutics - Pauses Enrollment in Phase 3 Alloha-2 Study of Tsc-101 Due to Insufficient Capital

THOMSON REUTERS

TScan Therapeutics - to Share Preclinical Data Q1 2027, File Ind Q3 2027, Initiate Phase 1 Q4 2027

THOMSON REUTERS

TScan Therapeutics - to Reduce Workforce by About 75% and Extend Cash Runway into Q4 2027

THOMSON REUTERS

TScan Therapeutics - Strategic Reorganization Expected to Produce Cost Savings of $55 Mln Through End of 2027

THOMSON REUTERS

TScan Therapeutics Announces Strategic Reorganization to Focus on in Vivo Cell Therapy for Solid Tumors

THOMSON REUTERS

TScan Therapeutics Announces Strategic Reorganization to Focus on in vivo Cell Therapy for Solid Tumors

European Wax Center Releases Limited Edition Golden Orchard Body Butter and Body Polish for Post-Wax Skincare

Lexeo Therapeutics to Participate in Upcoming Investor Conferences in September

NIQ announce further advancements in Agentic Commerce Measurement strategy

Coinbase Global: Some Users May be Experiencing Delayed Sends & Receives on Solana Network; Buys, Sells, Fiat Withdrawals/Deposits Remain Unaffected

THOMSON REUTERS

NIQ Partners with Similarweb to Develop Agentic Commerce Measurement Solution

Piper Sandler Adjusts Price Target on Robinhood Markets to $145 From $135, Keeps Overweight Rating

MT Newswires Live

U.S. Earnings Preview: Before Market Open Sept. 2

Robinhood Markets, Inc. : Piper Sandler Raises Target Price to $145 from $135

THOMSON REUTERS

TOKYO BASE Posts Double-Digit August Sales Growth on New Formats and Overseas Strength

Aptabio Therapeutics Plans Seoul NDR to Deepen R&D Dialogue with Institutions

Retail Employees Super Fund Exits Substantial Holding in PYC Therapeutics

Prescient Therapeutics Hits Dose Optimization Review Milestone in Cancer Drug Study

MT Newswires Live

Coinbase Drops Crucial Warning Amid Wrapped Zcash and HYPE Launch

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/BK4539/news?page=36"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":693.02655,"timestamp":1789156799999,"preClose":688.91504,"halted":0,"volume":272157313,"delay":0,"changeRate":0.005968,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":4.111511,"latestTime":"09-11 16:00:00 EDT","open":689.8237,"high":698.2087,"low":685.0665,"amount":8901943117.280722,"amplitude":0.019077,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.322141,"peRate":139.801509,"turnoverRate":0.021443,"increases":71,"decrements":69,"flats":10,"marketCap":479852364396.5,"floatMarketCap":365120021896},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":698.2087,"amplitude":0.019077,"preClose":688.91504,"low":685.0665,"pbRate":"5.322141","latestPrice":693.02655,"volume":272157313,"delay":0,"open":689.8237,"prevYearClose":881.5255,"prevWeekClose":725.2816,"prevMonthClose":701.0681,"prevQuarterClose":742.922,"fiveDayClose":733.4782,"twentyDayClose":682.8836,"sixtyDayClose":729.1859,"secType":"PLATE","market":"US","turnoverRate":0.021443,"peRate":139.801509,"marketCap":479852364396.5,"floatMarketCap":365120021896,"timestamp":1789156799999,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":71,"down":69,"flat":14},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:36,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664481517","title":"TScan Therapeutics Cuts Workforce 75% in Reorganization to Focus on in Vivo Solid Tumor Cell Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2664481517","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664481517?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:02","pubTimestamp":1788346932,"startTime":"0","endTime":"0","summary":"TScan Therapeutics cuts workforce 75% in reorganization to focus on in vivo solid tumor cell therapyTScan Therapeutics launched a strategic reorganization to prioritize in vivo TCR-T cell therapy for ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL7rnZG4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","IE00BQXX3D17.EUR","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","TCRX","LU2095319765.USD","BK4588","IE00BQXX3F31.USD","SG9999014039.USD","LU2210150020.SGD","NDAQ","LU2210149790.SGD","BK4112","BCDF","SG9999014005.SGD","BK4539","BK4585","IE00BKPKM429.USD","IE00BQXX3C00.GBP","LU0314104364.USD","SG9999014021.USD","IE00BN0W2V16.EUR","BK4139","IE00BGHQF748.EUR","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664815679","title":"TScan Therapeutics - Pauses Enrollment in Phase 3 Alloha-2 Study of Tsc-101 Due to Insufficient Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2664815679","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664815679?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:00","pubTimestamp":1788346801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nTUA3C44JY:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TCRX","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664815621","title":"TScan Therapeutics - to Share Preclinical Data Q1 2027, File Ind Q3 2027, Initiate Phase 1 Q4 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2664815621","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664815621?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:00","pubTimestamp":1788346801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nTUA3C44JY:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","TCRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664815573","title":"TScan Therapeutics - to Reduce Workforce by About 75% and Extend Cash Runway into Q4 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2664815573","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664815573?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:00","pubTimestamp":1788346801,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nTUA3C44JY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TCRX","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664815521","title":"TScan Therapeutics - Strategic Reorganization Expected to Produce Cost Savings of $55 Mln Through End of 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2664815521","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664815521?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:00","pubTimestamp":1788346801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nTUA3C44JY:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TCRX","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664815508","title":"TScan Therapeutics Announces Strategic Reorganization to Focus on in Vivo Cell Therapy for Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2664815508","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664815508?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:00","pubTimestamp":1788346801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nTUA3C44JY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","TCRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664815050","title":"TScan Therapeutics Announces Strategic Reorganization to Focus on in vivo Cell Therapy for Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2664815050","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664815050?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:00","pubTimestamp":1788346800,"startTime":"0","endTime":"0","summary":"Advances two in vivo-engineered TCR-T candidates for solid tumors to IND-enabling studies with plans to initiate Phase 1 development in Q4 2027 Reports updated data from Cohort C of the Phase 1 ALLOHA","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3354974/0/en/tscan-therapeutics-announces-strategic-reorganization-to-focus-on-in-vivo-cell-therapy-for-solid-tumors.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","EES","LENZ","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664777815","title":"European Wax Center Releases Limited Edition Golden Orchard Body Butter and Body Polish for Post-Wax Skincare","url":"https://stock-news.laohu8.com/highlight/detail?id=2664777815","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664777815?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:00","pubTimestamp":1788346800,"startTime":"0","endTime":"0","summary":"The new fall scent, launching nationwide today, joins the award-winning EWC SLOW line PLANO, Texas, Sept.  02, 2026 (GLOBE NEWSWIRE) -- European Wax Center, Inc., the leading franchisor and operator o","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3354989/0/en/european-wax-center-releases-limited-edition-golden-orchard-body-butter-and-body-polish-for-post-wax-skincare.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EPV","BK4539","BK4192","EWCZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664150968","title":"Lexeo Therapeutics to Participate in Upcoming Investor Conferences in September","url":"https://stock-news.laohu8.com/highlight/detail?id=2664150968","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664150968?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:00","pubTimestamp":1788346800,"startTime":"0","endTime":"0","summary":"NEW YORK, Sept.  02, 2026 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO) a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, to","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3354967/0/en/lexeo-therapeutics-to-participate-in-upcoming-investor-conferences-in-september.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4130","LXEO","BK4535","BK4139","FA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664815179","title":"NIQ announce further advancements in Agentic Commerce Measurement strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2664815179","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664815179?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:55","pubTimestamp":1788346509,"startTime":"0","endTime":"0","summary":"NIQ (NIQ) announced further advancements in its Agentic Commerce Measurement strategy through a collaboration with Similarweb (SMWB). The companies...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/niq-announce-further-advancements-in-agentic-commerce-measurement-strategy-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/niq-announce-further-advancements-in-agentic-commerce-measurement-strategy-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NIQ","BK4539","BK4009","SMWB","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664392815","title":"Coinbase Global: Some Users May be Experiencing Delayed Sends & Receives on Solana Network; Buys, Sells, Fiat Withdrawals/Deposits Remain Unaffected","url":"https://stock-news.laohu8.com/highlight/detail?id=2664392815","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664392815?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:52","pubTimestamp":1788346348,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44U016:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COIG","07311","DAPP","07711","BK4595","ICOI","LU2360107671.USD","LU1861558580.USD","BK4600","COIW","SOLX","BK4588","BK4585","SLON","COIO","COIN","CONY","COYY","CRPT","BK4535","SOLT","SSK","FINX","BKCH","BITQ","FIAT","BK4516","COII","SOL.USD.CC","09711","COIX","CONX","CONI","LU1861217088.USD","COIA","IBLC","LU1861559042.SGD","BK4112","LU1861220207.SGD","BK4551","BK4596","09311","SOLZ","BLCK","BK4554","FDIG","CONL","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664813017","title":"NIQ Partners with Similarweb to Develop Agentic Commerce Measurement Solution","url":"https://stock-news.laohu8.com/highlight/detail?id=2664813017","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664813017?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:45","pubTimestamp":1788345927,"startTime":"0","endTime":"0","summary":"NIQ partners with Similarweb to develop agentic commerce measurement solutionNIQ Global Intelligence partnered with Similarweb to develop an agentic commerce measurement product for AI-driven shopping","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL50MPqc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SMWB","BK4023","BK4539","NIQ","BK4009"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664818166","title":"Piper Sandler Adjusts Price Target on Robinhood Markets to $145 From $135, Keeps Overweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2664818166","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664818166?lang=en_us&edition=fundamental","pubTime":"2026-09-02 17:58","pubTimestamp":1788343113,"startTime":"0","endTime":"0","summary":"Robinhood Markets (HOOD) has an average rating of overweight and mean price target of $126.64, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HOOG","BLCK","CRPT","IAI","HOOY","BK4547","BK4539","HOOX","FINX","BPAY","LU1861559042.SGD","HOII","BK4127","HOOC","HOOI","LU1861558580.USD","HOYY","HODU","HOOD","HOOW","ROBN","HOOZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664497890","title":"U.S. Earnings Preview: Before Market Open Sept. 2","url":"https://stock-news.laohu8.com/highlight/detail?id=2664497890","media":"Dow Jones","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664497890?lang=en_us&edition=fundamental","pubTime":"2026-09-02 17:31","pubTimestamp":1788341460,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.The following companies are among those expected to report their latest financial results before the market opens.Ollie's Bargain Outlet Holdings Inc.'s second-quarter EPS is forecast at $1.12, compared with 99 cents in the prior-year period.Sprinklr Inc.'s second-quarter EPS is forecast at a loss of 14 cents. Adjusted EPS is forecast at 10 cents.G-III Apparel Group Ltd.'s second-quarter EPS is forecast at 21 cents, compared with 25 cents in the prior-year period. Adjusted EPS is forecast at 23 cents.Daktronics Inc.'s first-quarter EPS is forecast at 35 cents, compared with 33 cents in the prior-year period.Generated from Dow Jones Calendar Live with data from Dow Jones and Factset.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4157","BK4202","BK4539","CXM","BK4114","BK4220","OLLI","DAKT","BK4023","GIII"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664894923","title":"Robinhood Markets, Inc. : Piper Sandler Raises Target Price to $145 from $135","url":"https://stock-news.laohu8.com/highlight/detail?id=2664894923","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664894923?lang=en_us&edition=fundamental","pubTime":"2026-09-02 15:37","pubTimestamp":1788334625,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44U0IC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HOOZ","HOOX","LU1861558580.USD","HOOG","HOOY","CRPT","HOOC","HOII","ROBN","HOOI","IAI","HOYY","HOOW","BLCK","BK4539","HODU","LU1861559042.SGD","BPAY","FINX","HOOD","BK4547","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664891652","title":"TOKYO BASE Posts Double-Digit August Sales Growth on New Formats and Overseas Strength","url":"https://stock-news.laohu8.com/highlight/detail?id=2664891652","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664891652?lang=en_us&edition=fundamental","pubTime":"2026-09-02 14:53","pubTimestamp":1788332027,"startTime":"0","endTime":"0","summary":"TOKYO BASE Co., Ltd. ( ($JP:3415) ) just unveiled an update. TOKYO BASE reported solid trading for August 2026, with total net sales rising 17.2% y...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tokyo-base-posts-double-digit-august-sales-growth-on-new-formats-and-overseas-strength?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tokyo-base-posts-double-digit-august-sales-growth-on-new-formats-and-overseas-strength?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4023","BK4116","BASE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664997828","title":"Aptabio Therapeutics Plans Seoul NDR to Deepen R&D Dialogue with Institutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2664997828","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664997828?lang=en_us&edition=fundamental","pubTime":"2026-09-02 14:21","pubTimestamp":1788330080,"startTime":"0","endTime":"0","summary":"Aptabio Therapeutics, Inc. ( ($KR:293780) ) has provided an update. Aptabio Therapeutics, Inc., a biotechnology company focused on research and dev...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aptabio-therapeutics-plans-seoul-ndr-to-deepen-rd-dialogue-with-institutions?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aptabio-therapeutics-plans-seoul-ndr-to-deepen-rd-dialogue-with-institutions?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LNGR","XT","AGNG","DARP","FWD","LENZ","RSPH","BBP","JDOC","BK4585","IBB","FHLC","BK4007","BK4139","BK4588","SYNB","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664996128","title":"Retail Employees Super Fund Exits Substantial Holding in PYC Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2664996128","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664996128?lang=en_us&edition=fundamental","pubTime":"2026-09-02 14:15","pubTimestamp":1788329749,"startTime":"0","endTime":"0","summary":"An announcement from PYC Therapeutics Limited ( ($AU:PYC) ) is now available. Retail Employees Superannuation Pty Ltd, acting as trustee of the Ret...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/retail-employees-super-fund-exits-substantial-holding-in-pyc-therapeutics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/retail-employees-super-fund-exits-substantial-holding-in-pyc-therapeutics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LENZ","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664999896","title":"Prescient Therapeutics Hits Dose Optimization Review Milestone in Cancer Drug Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2664999896","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664999896?lang=en_us&edition=fundamental","pubTime":"2026-09-02 13:38","pubTimestamp":1788327489,"startTime":"0","endTime":"0","summary":"Prescient Therapeutics  reached the pre-specified enrollment threshold for its first planned dose optimization committee review in a phase 2a study of its PTX-100 drug candidate in relapsed or refractory cutaneous T-cell lymphoma, according to a Wednesday filing with the Australian bourse.The company said 10 evaluable patients, or those who have completed four cycles of treatment, are now enrolled in each of the study's two dosing arms for 20 evaluable patients in total.The first dose optimization committee review remains on track for December, and enrollment in the study continues globally toward a full target of 40 evaluable patients.Cutaneous T-cell lymphoma is a type of immune system cancer where abnormal white blood cells migrate to and attack the skin.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","LENZ","BK7508","BK4139","BK4539","PTX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664516827","title":"Coinbase Drops Crucial Warning Amid Wrapped Zcash and HYPE Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2664516827","media":"utoday","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664516827?lang=en_us&edition=fundamental","pubTime":"2026-09-02 11:40","pubTimestamp":1788320400,"startTime":"0","endTime":"0","summary":"Major crypto exchange Coinbase has added support for two new wrapped assets: Zcash (ZEC) and Hyperliquid (HYPE).In a recent post, Coinbase announced that cbHYPE and cbZEC are now live on Base. Zcash a","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"utodaynews_highlight","url":"https://u.today/coinbase-drops-crucial-warning-amid-wrapped-zcash-and-hype-launch","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://u.today/coinbase-drops-crucial-warning-amid-wrapped-zcash-and-hype-launch","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"utodaynews_highlight","symbols":["07311","BITQ","COIX","LU1861559042.SGD","BK4516","IBLC","ICOI","09711","COYY","BLCK","COIW","CONX","COIN","FINX","BK4551","LU1861558580.USD","FIAT","BK4535","COIO","BK4595","CONL","LU1861220207.SGD","BK4554","07711","FDIG","COIA","LU2360107671.USD","BKCH","CONI","BK4596","CONY","LU1861217088.USD","09311","BK4585","BK4600","BK4588","COII","BK4112","BK4539","COIG"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":45,"pageCount":36,"totalSize":898,"code":"91000000","status":"200"}]}}